Israel Active

Israeli scientists and doctors have induced the self-destruction of pancreatic cancer cells in mice. A small molecule, PJ34, normally used to treat stroke victims, reduced cancer cells by up to 90 percent a month. There were no adverse effects. Normal cells were unaffected.

Over a thousand participants gathered in Tel Aviv for the second annual Digital.Health.Now conference. It focused on showcasing advanced Israeli innovations in telemedicine, digital healthcare, and general wellness aided by technology.

Last week 50 members of our synagogue were privileged to be given a tour of Emergency Service United Hatzalah’s headquarters in Jerusalem.  United Hatzalah’s volunteer EMTs arrive at the scene of an incident within three minutes, often saving lives in Israel.  Click the link to read a recent typical example.

Zone7, founded by IDF veterans, uses AI to foresee and prevent injuries to sports people. It advertises an 80% reduction in injury days and provides coaches, trainers and sports scientists with intervention strategies. Zone7 is partnering its platform with global medical company Garmin Health.

Another Israeli product showcased at Israel’s Digital.Health.Now conference was Calmigo. Its advanced technology provides immediate, drug-free relief for moments of distress, anxiousness, and stress by regulating your breathing patterns and stimulating your senses.

One Israeli startup at the Digital.Health.Now conference was RightHear. . This video shows how the blind use its technology to access the functions on a Smartphone. Also, (TY Jacques) RightHear is supporting the first official blind-friendly street in Israel, and possibly the world.

Israel’s Teva and Tel Aviv University have signed an R&D agreement in the fields of cancer and brain studies. Teva has also partnered with Israel’s Weizmann Institute to identify the next generation of innovative antibodies for cancer treatment.

21 bipartisan US lawmakers have requested that the US establishes an FDA office in Israel to facilitate collaboration in life-saving research. They wrote that Israel’s world class medical research programs have positively impacted the global health system.

To coincide with World AIDS day, Robert Sarner wrote this article about Israeli-born Dr Neora Pick. As medical director of Canada’s only multidisciplinary clinic for women and children with HIV, she treats some of the 63,000 (and increasing) Canadians with HIV.

As predicted previously, the OLO finger prick blood test device from Israel’s Sight Diagnostics flowed through the US FDA approval process.  It enables use of the CBC (Complete Blood Test) device in laboratories run by hospitals, diagnostic providers, and outpatient clinics.